STING1 and neoplasm: As a representative of immunotherapy, the STING activator cGAMP combined with OXA not only enhances cytotoxicity and promotes the immunogenic cell death of tumor cells [36] but also provides a stronger anti-tumor response through the synergistic activation of STING, which activates innate immunity.